Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis We…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis We…
この記事を読む
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer. Saiki M et al.…
この記事を読む
Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment. Silva M…
この記事を読む
免疫チェックポイント阻害薬を2次治療で使った場合、臨床試験で延命効果は証明されていますが「よく効いている」という実感はあまりありません。この「効く感触」は、腫瘍縮小効果と無増悪生存期間を足して2で割ったような感触(?)なので、以下の話は雑談…
この記事を読む
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. Horn L et al. N Engl J Med. 2018 Se…
この記事を読む
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With…
この記事を読む
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With E…
この記事を読む
Surgically Treated Unsuspected N2-Positive NSCLC: Role of Extent and Location of Lymph Node Metastasis. Andersson S Clin…
この記事を読む
Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: A propensity…
この記事を読む
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in P…